FDA, Zeneca Pharmaceuticals warn of increased uterine-cancer risk with tamoxifen treatment.
D004345:Drug Industry; D005260:Female; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D013629:Tamoxifen / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration; D014594:Uterine Neoplasms / Q000139:chemically induced*
D013629:Tamoxifen